BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 321157)

  • 1. Drug-induced immunological unresponsiveness: selective inhibition of T-cell 'helper function' by cyclophosphamide in mice pretreated with phytohaemagglutinin.
    Schwarze G
    Clin Exp Immunol; 1977 Jan; 27(1):178-82. PubMed ID: 321157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
    Dennert G; Hatlen LE; Tucker DF
    J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.
    Stevenson HC; Fauci AS
    Immunology; 1980 Mar; 39(3):391-7. PubMed ID: 7002766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
    Gill HK; Liew FY
    Eur J Immunol; 1978 Mar; 8(3):172-6. PubMed ID: 306925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The nature of immunodeficiency induced by injections of lectins and cyclophosphamide].
    Kondrat'eva TK; Mikheeva NV; Fontalin LN
    Biull Eksp Biol Med; 1988 Aug; 106(8):195-8. PubMed ID: 3261998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role of L3T4+ antigen in the Con A response of regenerating splenic L3T4+ T cells after Cy treatment.
    Ikezawa Z; Sato M; Aoki I
    Immunology; 1987 Mar; 60(3):375-82. PubMed ID: 3106196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular kinetics of the primary immune response after application of phytohemagglutinin].
    Hegedüs VM; Schramm-Thiel N; Wacker A
    Arzneimittelforschung; 1975 Feb; 25(2):222-3. PubMed ID: 1091271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.
    Shand FL
    Immunology; 1978 Dec; 35(6):1017-25. PubMed ID: 33118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.
    Lagrange PH; Mackaness GB; Miller TE
    J Exp Med; 1974 Jun; 139(6):1529-39. PubMed ID: 4598017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclophosphamide on the in vivo response of outbred athymic (nude) mice to a thymus-independent antigen (DNP-AGG-Ficoll).
    Snippe H; Merchant B; Johannessen L; Inman JK
    Immunology; 1978 Dec; 35(6):1009-15. PubMed ID: 367956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency detection of different T-cell subsets in mice by a modified virus plaque assay.
    Fujisawa H; Kumazawa Y; Ohtani A; Nishimura C
    Immunology; 1983 May; 49(1):175-81. PubMed ID: 6601613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.
    Brodeur BR; Merigan TC
    J Immunol; 1975 Apr; 114(4):1323-8. PubMed ID: 163863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro.
    Varkila K; Hurme M
    Immunology; 1983 Mar; 48(3):433-8. PubMed ID: 6219062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of type III pneumococcal polysaccharide-specific suppressor T cells in cyclophosphamide-treated mice requirement for recognition of antigen and I-J determinants on antigen coupled to syngeneic spleen cells.
    Braley-Mullen H
    J Immunol; 1983 Nov; 131(5):2190-5. PubMed ID: 6195257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of splenic T cell proliferation by lipid A in mice immunized with sheep red blood cells.
    Mita A; Ohta H; Mita T
    J Immunol; 1982 Apr; 128(4):1709-11. PubMed ID: 7037954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.
    Cerny J; Stiller RA
    J Immunol; 1975 Oct; 115(4):943-9. PubMed ID: 170339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
    Sihvola M; Hurme M
    J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of T-cell function and induction of antitumor immune response in T-cell-depressed spontaneously hypertensive rats by treatment with thymosin fraction 5.
    Takeichi N; Koga Y; Fujii T; Kobayashi H
    Cancer Res; 1985 Feb; 45(2):487-91. PubMed ID: 3871352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.